/ /

Lisette Hilton
Lisette Hilton is a writer in Boca Raton, Fla., who heads up her company, Words Come Alive.
Urologists positive about abiraterone integration
More than 96% of urologists surveyed said that incorporating abiraterone acetate (ZYTIGA) treatment into practice for patients with metastatic castrate-resistant prostate cancer is easy or manageable after overcoming initial barriers, according to new research presented at the Genitourinary Cancers Symposium in Orlando, FL.
Software could help prevent post-cystectomy readmission
Researchers have developed software that can generate, in real time, whether a radical cystectomy patient is likely to be rehospitalized and when the urologist should follow up with the patient.
NMIBC guideline compliance remains low
Urologists’ compliance with nonmuscle-invasive bladder cancer guidelines has improved with respect to delivery of perioperative mitomycin, but other care measures continue to be suboptimal, according to a new study.
Surveillance rarely used in stage 1, 2 prostate Ca
While close to 90% of men diagnosed with prostate cancer between 1998 and 2012 had stage 1 and stage 2 disease, more than 90% underwent surgery or radiation to treat the cancer, according to a study presented at the Genitourinary Cancers Symposium in Orlando, FL.
Prostate Ca test influences decision-making post RP
“From our results, the Decipher test helps reassure low-risk patients that observation may be warranted or confirm that high-risk patients need additional treatment,” says study author John L. Gore, MD, MSHS.
Vaginal rejuvenation and the cosmetic practice
It’s proving to be a viable addition to the scope of service in the cosmetic practice, but be forewarned: It’s serious business.
Online information linked to PCa treatment regret
Men who use the Internet as their primary source for prostate cancer treatment decision-making are more likely to regret those decisions a year after treatment than those whose primary sources of information are radiation oncologists or urologists.
First national urology-wide registry gathers steam
The AUA-sponsored AQUA Registry is gaining momentum as more U.S. urologists choose to sign on with the first national urology-wide registry for quality reporting and more.
ASCO issues guidance on second-line hormonal Tx in CRPC
The American Society of Clinical Oncology’s provisional clinical opinion on the use of second-line hormonal therapy for chemotherapy-naïve men with castration-resistant prostate cancer issued by uncovered some surprising findings and issues.
Sleep duration linked to PCa mortality risk in younger men
Results of a recent study support a growing body of evidence that factors associated with circadian rhythm disruption might play a role in prostate carcinogenesis.

Poll

View Results